Entry |
|
Name |
Cefoperazone sodium and sulbactam sodium (JP18); Sulperazon (TN) |
Component |
Sulbactam sodium [DR: D02223], Cefoperazone sodium [DR: D00918]
|
Remark |
Therapeutic category: | 6139 |
|
Efficacy |
Antibacterial |
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01D OTHER BETA-LACTAM ANTIBACTERIALS
J01DD Third-generation cephalosporins
J01DD62 Cefoperazone and beta-lactamase inhibitor
D08772 Cefoperazone sodium and sulbactam sodium (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
61 Antibiotics
613 Acting mainly on gram-positive and gram-negative bacteria
6139 Others
D08772 Cefoperazone sodium and sulbactam sodium (JP18)
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Third-generation cephalosporin
D08772 Cefoperazone sodium and sulbactam sodium (JP18) <JP>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Third-generation cephalosporin
D08772 Cefoperazone sodium and sulbactam sodium (JP17)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D08772 Cefoperazone sodium and sulbactam sodium for injection
|
Other DBs |
|
LinkDB |
|
|